Concepedia

Robert Laplanche

RL

Statistics

Publications

7

Citations

238

H-Index

7

Active since

1988

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Robert Laplanche is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and pharmacokinetics.

Top concepts

Publications per year

1988–2007

7

Publications

7

Preferential Cerebrospinal Fluid Acetylcholinesterase Inhibition by Rivastigmine in Humans

John Kennedy, Ronald J. Polinsky, Benjamin Johnson et al. · Journal of Clinical Psychopharmacology · 1999 · 74 citations

, , +17

Intragastric Behavior and Absorption Kinetics of a Normal and “Floating” Modified-Release Capsule of Isradipine under Fasted and Fed Conditions

Norman A. Mazer, E. Abisch, Jean‐Claude Gfeller et al. · Journal of Pharmaceutical Sciences · 1988 · 41 citations

, , +4

Physiologically Based Pharmacokinetic (PBPK) Modeling of Everolimus (RAD001) in Rats Involving Non-Linear Tissue Uptake

Robert Laplanche, Guy Meno‐Tetang, Ryosei Kawai · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 36 citations

, , +5

Absorption, Metabolism, and Disposition of [14C]SDZ ENA 713, an Acetylcholinesterase Inhibitor, in Minipigs Following Oral, Intravenous, and Dermal Administration

Francis L. S. Tse, Robert Laplanche · Pharmaceutical Research · 1998 · 28 citations

Assay of isradipine and of its major metabolites in biological fluids by capillary gas chromatography and chemical ionization mass spectrometry

Christian Jean, Robert Laplanche · Journal of Chromatography B Biomedical Sciences and Applications · 1988 · 27 citations

, , +14

1–5 of 7